{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:05:54Z","timestamp":1767409554924},"publisher-location":"Cham","reference-count":40,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319997155"},{"type":"electronic","value":"9783319997162"}],"license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-319-99716-2_9","type":"book-chapter","created":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T11:33:57Z","timestamp":1546169637000},"page":"185-193","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatosplenic T-Cell Lymphomas"],"prefix":"10.1007","author":[{"given":"Lohith","family":"Gowda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1056\/NEJM198103123041106","volume":"304","author":"ME Kadin","year":"1981","unstructured":"Kadin ME, Kamoun M, Lamberg J (1981) Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis. N Engl J Med 304:648\u2013653","journal-title":"N Engl J Med"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","volume":"75","author":"JP Farcet","year":"1990","unstructured":"Farcet JP, Gaulard P, Marolleau JP et al (1990) Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 75:2213\u20132219","journal-title":"Blood"},{"key":"9_CR3","doi-asserted-by":"crossref","unstructured":"Vose J, Armitage J, Weisenburger D (2008) International TCLP. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124\u20134130","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.4265","volume":"88","author":"CB Cooke","year":"1996","unstructured":"Cooke CB, Krenacs L, Stetler-Stevenson M et al (1996) Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 88:4265\u20134274","journal-title":"Blood"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.4049\/jimmunol.142.9.3045","volume":"142","author":"RP Bucy","year":"1989","unstructured":"Bucy RP, Chen CL, Cooper MD (1989) Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans. J Immunol 142:3045\u20133049","journal-title":"J Immunol"},{"key":"9_CR6","first-page":"617","volume":"137","author":"P Gaulard","year":"1990","unstructured":"Gaulard P, Bourquelot P, Kanavaros P et al (1990) Expression of the alpha\/beta and gamma\/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma\/delta T-cell lymphomas. Am J Pathol 137:617\u2013628","journal-title":"Am J Pathol"},{"key":"9_CR7","first-page":"401","volume":"132","author":"LJ Picker","year":"1988","unstructured":"Picker LJ, Brenner MB, Michie S, Warnke RA (1988) Expression of T cell receptor delta chains in benign and malignant T lineage lymphoproliferations. Am J Pathol 132:401\u2013405","journal-title":"Am J Pathol"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-065X.2006.00472.x","volume":"215","author":"B Moser","year":"2007","unstructured":"Moser B, Eberl M (2007) Gammadelta T cells: novel initiators of adaptive immunity. Immunol Rev 215:89\u2013102","journal-title":"Immunol Rev"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2015.04.008","volume":"296","author":"EJ Adams","year":"2015","unstructured":"Adams EJ, Gu S, Luoma AM (2015) Human gamma delta T cells: evolution and ligand recognition. Cell Immunol 296:31\u201340","journal-title":"Cell Immunol"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1084\/jem.173.2.499","volume":"173","author":"H Koizumi","year":"1991","unstructured":"Koizumi H, Liu CC, Zheng LM et al (1991) Expression of perforin and serine esterases by human gamma\/delta T cells. J Exp Med 173:499\u2013502","journal-title":"J Exp Med"},{"key":"9_CR11","first-page":"960252","volume":"2014","author":"Y He","year":"2014","unstructured":"He Y, Wu K, Hu Y et al (2014) Gammadelta T cell and other immune cells crosstalk in cellular immunity. J Immunol Res 2014:960252","journal-title":"J Immunol Res"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","volume":"6","author":"C Tripodo","year":"2009","unstructured":"Tripodo C, Iannitto E, Florena AM et al (2009) Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 6:707\u2013717","journal-title":"Nat Rev Clin Oncol"},{"issue":"36\u201341","key":"9_CR13","first-page":"e31","volume":"9","author":"DS Kotlyar","year":"2011","unstructured":"Kotlyar DS, Osterman MT, Diamond RH et al (2011) A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 9(36\u201341):e31","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0037-1963(03)00137-9","volume":"40","author":"P Gaulard","year":"2003","unstructured":"Gaulard P, Belhadj K, Reyes F (2003) Gammadelta T-cell lymphomas. Semin Hematol 40:233\u2013243","journal-title":"Semin Hematol"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2008-07-166363","volume":"113","author":"K Miyazaki","year":"2009","unstructured":"Miyazaki K, Yamaguchi M, Imai H et al (2009) Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma. Blood 113:1071\u20131074","journal-title":"Blood"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","volume":"119","author":"M Travert","year":"2012","unstructured":"Travert M, Huang Y, de Leval L et al (2012) Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. Blood 119:5795\u20135806","journal-title":"Blood"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/leu.2014.200","volume":"28","author":"A Nicolae","year":"2014","unstructured":"Nicolae A, Xi L, Pittaluga S et al (2014) Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas. Leukemia 28:2244\u20132248","journal-title":"Leukemia"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","volume":"7","author":"M McKinney","year":"2017","unstructured":"McKinney M, Moffitt AB, Gaulard P et al (2017) The genetic basis of hepatosplenic T-cell lymphoma. Cancer Discov 7:369\u2013379","journal-title":"Cancer Discov"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ajcp\/102.3.310","volume":"102","author":"CW Ross","year":"1994","unstructured":"Ross CW, Schnitzer B, Sheldon S, Braun DK, Hanson CA (1994) Gamma\/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol 102:310\u2013315","journal-title":"Am J Clin Pathol"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood.V81.10.2688.2688","volume":"81","author":"P Kanavaros","year":"1993","unstructured":"Kanavaros P, Lescs MC, Briere J et al (1993) Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81:2688\u20132695","journal-title":"Blood"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2559.2000.00804.x","volume":"36","author":"K Ohshima","year":"2000","unstructured":"Ohshima K, Haraoka S, Harada N et al (2000) Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology 36:127\u2013135","journal-title":"Histopathology"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","volume":"102","author":"K Belhadj","year":"2003","unstructured":"Belhadj K, Reyes F, Farcet JP et al (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102:4261\u20134269","journal-title":"Blood"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/sj.leu.2401784","volume":"14","author":"E Weidmann","year":"2000","unstructured":"Weidmann E (2000) Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 14:991\u2013997","journal-title":"Leukemia"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/1523-1747.ep12470953","volume":"96","author":"E Berti","year":"1991","unstructured":"Berti E, Cerri A, Cavicchini S et al (1991) Primary cutaneous gamma\/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol 96:718\u2013723","journal-title":"J Invest Dermatol"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0625.1992.tb00069.x","volume":"1","author":"E Ralfkiaer","year":"1992","unstructured":"Ralfkiaer E, Wollf-Sneedorff A, Thomsen K, Geisler C, Vejlsgaard GL (1992) T-cell receptor gamma delta-positive peripheral T-cell lymphomas presenting in the skin: a clinical, histological and immunophenotypic study. Exp Dermatol 1:31\u201336","journal-title":"Exp Dermatol"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/gcc.10021","volume":"33","author":"I Wlodarska","year":"2002","unstructured":"Wlodarska I, Martin-Garcia N, Achten R et al (2002) Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosom Cancer 33:243\u2013251","journal-title":"Genes Chromosom Cancer"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","volume":"40","author":"M Yabe","year":"2016","unstructured":"Yabe M, Medeiros LJ, Tang G et al (2016) Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases. Am J Surg Pathol 40:676\u2013688","journal-title":"Am J Surg Pathol"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1245\/s10434-009-0470-0","volume":"16","author":"AA Gumbs","year":"2009","unstructured":"Gumbs AA, Zain J, Neylon E, MacGregor-Cortelli B, Patterson M, O\u2019Connor OA (2009) Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia. Ann Surg Oncol 16:2014\u20132017","journal-title":"Ann Surg Oncol"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijsu.2013.11.017","volume":"12","author":"EP Weledji","year":"2014","unstructured":"Weledji EP (2014) Benefits and risks of splenectomy. Int J Surg 12:113\u2013119","journal-title":"Int J Surg"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1600-0609.2010.01411.x","volume":"84","author":"Y Takamatsu","year":"2010","unstructured":"Takamatsu Y, Suzumiya J, Utsunomiya A et al (2010) THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia\/lymphoma: a multicenter phase II study. Eur J Haematol 84:391\u2013397","journal-title":"Eur J Haematol"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","volume":"13","author":"MH Voss","year":"2013","unstructured":"Voss MH, Lunning MA, Maragulia JC et al (2013) Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. Clin Lymphoma Myeloma Leuk 13:8\u201314","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","volume":"20","author":"GS Falchook","year":"2009","unstructured":"Falchook GS, Vega F, Dang NH et al (2009) Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 20:1080\u20131085","journal-title":"Ann Oncol"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","volume":"19","author":"G Jaeger","year":"2008","unstructured":"Jaeger G, Bauer F, Brezinschek R, Beham-Schmid C, Mannhalter C, Neumeister P (2008) Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine. Ann Oncol 19:1025\u20131026","journal-title":"Ann Oncol"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","volume":"76","author":"S Mittal","year":"2006","unstructured":"Mittal S, Milner BJ, Johnston PW, Culligan DJ (2006) A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. Eur J Haematol 76:531\u2013534","journal-title":"Eur J Haematol"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/10428190500293321","volume":"47","author":"ML Moleti","year":"2006","unstructured":"Moleti ML, Testi AM, Giona F et al (2006) Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone. Leuk Lymphoma 47:333\u2013336","journal-title":"Leuk Lymphoma"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/ajh.21062","volume":"83","author":"SK Tey","year":"2008","unstructured":"Tey SK, Marlton PV, Hawley CM, Norris D, Gill DS (2008) Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen. Am J Hematol 83:330\u2013333","journal-title":"Am J Hematol"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2014.280","volume":"29","author":"A Tanase","year":"2015","unstructured":"Tanase A, Schmitz N, Stein H et al (2015) Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT lymphoma working party. Leukemia 29:686\u2013688","journal-title":"Leukemia"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"e318","DOI":"10.1038\/bcj.2015.43","volume":"5","author":"A Rashidi","year":"2015","unstructured":"Rashidi A, Cashen AF (2015) Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma. Blood Cancer J 5:e318","journal-title":"Blood Cancer J"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1371\/journal.pgen.0030167","volume":"3","author":"R Opavsky","year":"2007","unstructured":"Opavsky R, Wang SH, Trikha P et al (2007) CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet 3:1757\u20131769","journal-title":"PLoS Genet"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/ncomms7025","volume":"6","author":"C Kucuk","year":"2015","unstructured":"Kucuk C, Jiang B, Hu X et al (2015) Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells. Nat Commun 6:6025","journal-title":"Nat Commun"}],"container-title":["Cancer Treatment and Research","T-Cell and NK-Cell Lymphomas"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-99716-2_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T11:09:30Z","timestamp":1694516970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-99716-2_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"ISBN":["9783319997155","9783319997162"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-99716-2_9","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"type":"print","value":"0927-3042"},{"type":"electronic","value":"2509-8497"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}